Kymera Therapeutics, Inc. (KYMR)
115.81
+0.34
(+0.29%)
USD |
NASDAQ |
Sep 24, 16:00
115.97
+0.16
(+0.14%)
Pre-Market: 19:59
Kymera Therapeutics Gross Profit (Annual) : 30.90M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 30.90M |
| December 31, 2024 | 39.70M |
| December 31, 2023 | 75.03M |
| December 31, 2022 | 43.85M |
| Date | Value |
|---|---|
| December 31, 2021 | 70.44M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 2.109M |
| December 31, 2018 | -0.205M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Oncolytics Biotech, Inc. | -0.07M |
| Sangamo Therapeutics, Inc. | 31.95M |
| Sarepta Therapeutics, Inc. | 1.314B |
| Anixa Biosciences, Inc. | -0.036M |